Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of 28.79% is 1751% above its 5-year average of 1.56%, near the high end of its 5-year range (-9.67%–28.79%).
227.35% above its 12-month average of 8.79%.
Reported quarterly return on assets; no daily interpolation. Q2 FY2026 (2026-06-30): 9.89%.
RETURN ON ASSETS (ROA)
28.79%
RETURN ON ASSETS (ROA) AVG TTM
8.79%
RETURN ON ASSETS (ROA) AVG 3Y
1.95%
RETURN ON ASSETS (ROA) AVG 5Y
1.56%
RETURN ON ASSETS (ROA) AVG 10Y
N/A
RETURN ON ASSETS (ROA) AVG 15Y
N/A
RETURN ON ASSETS (ROA) AVG 20Y
N/A
CURRENT VS TTM AVG
+227.35%
CURRENT VS 3Y AVG
+1374.52%
CURRENT VS 5Y AVG
+1751.45%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-32.24%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
+189.30%
vs the sector median at left
Indivior Pharmaceuticals Inc
Market Cap
$4.46B
Return on Assets (ROA)
28.79%
TTM Avg
8.79%
3Y Avg
1.95%
5Y Avg
1.56%
Market Cap
$4.42B
Return on Assets (ROA)
-34.36%
TTM Avg
-56.86%
3Y Avg
-55.14%
5Y Avg
-55.14%
Market Cap
$4.37B
Return on Assets (ROA)
-9.97%
TTM Avg
-20.59%
3Y Avg
-24.65%
5Y Avg
-22.36%
Market Cap
$4.29B
Return on Assets (ROA)
-41.11%
TTM Avg
-28.92%
3Y Avg
-26.43%
5Y Avg
-22.29%
Market Cap
$4.65B
Return on Assets (ROA)
6.20%
TTM Avg
6.10%
3Y Avg
6.22%
5Y Avg
4.90%
Market Cap
$4.67B
Return on Assets (ROA)
4.59%
TTM Avg
-6.29%
3Y Avg
-18.57%
5Y Avg
-18.57%
Market Cap
$4.68B
Return on Assets (ROA)
2.32%
TTM Avg
-1.14%
3Y Avg
-5.25%
5Y Avg
-6.57%
Market Cap
$4.68B
Return on Assets (ROA)
-31.79%
TTM Avg
-38.86%
3Y Avg
-47.00%
5Y Avg
-47.76%
Market Cap
$4.73B
Return on Assets (ROA)
-2.47%
TTM Avg
-26.65%
3Y Avg
-27.96%
5Y Avg
-27.52%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Indivior Pharmaceuticals Inc (INDV) | $4.46B | 28.79% | 8.79% | 1.95% | 1.56% |
| Heartflow, Inc. Common Stock (HTFL)vs › | $4.42B | -34.36% | -56.86% | -55.14% | -55.14% |
| Adaptive Biotechnologies Corporation (ADPT)vs › | $4.37B | -9.97% | -20.59% | -24.65% | -22.36% |
| Edgewise Therapeutics, Inc. (EWTX)vs › | $4.29B | -41.11% | -28.92% | -26.43% | -22.29% |
| Option Care Health, Inc. (OPCH)vs › | $4.65B | 6.20% | 6.10% | 6.22% | 4.90% |
| BillionToOne, Inc. (BLLN)vs › | $4.67B | 4.59% | -6.29% | -18.57% | -18.57% |
| LifeStance Health Group, Inc. (LFST)vs › | $4.68B | 2.32% | -1.14% | -5.25% | -6.57% |
| Definium Therapeutics, Inc. (DFTX)vs › | $4.68B | -31.79% | -38.86% | -47.00% | -47.76% |
| Dianthus Therapeutics, Inc. (DNTH)vs › | $4.73B | -2.47% | -26.65% | -27.96% | -27.52% |
| LivaNova PLC (LIVN)vs › | $4.13B | 7.14% | -3.40% | -2.46% | -5.09% |
ROA
28.8%
ROE
N/A
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | 17.44% |
| 2024-12-31 | 0.15% |
| 2023-12-31 | -7.31% |
| 2022-12-31 | -2.47% |
| 2021-12-31 | 11.19% |
| 2020-12-31 | -9.67% |
| 2019-12-31 | 8.11% |
| 2018-12-31 | 16.98% |
| 2017-12-31 | 4.22% |
| 2016-12-31 | 2.65% |
